Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 148, Issue 2, 2010, Pages 186-190

  Mehu Parant, Françoise ^a   Rouzier, Roman ^b   Soulat, Jean Marc ^a,c,d   Parant, Olivier ^e  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b HÔPITAL TENON   (France)

^c INSERM   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e Paul Sabatier University   (France)

Author keywords

College; Healthcare; Human papillomavirus; Vaccination; Vaccine acceptability

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; DEMOGRAPHY; FEMALE; FRANCE; GROUPS BY AGE; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN EXPERIMENT; KNOWLEDGE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; UNIVERSITY STUDENT; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EID: 73749086154     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.10.024     Document Type: Article

References (12)

1. Koulova A., Tsui J., Irwin K., Van Damme P., Biellik R., and Aguado M.T. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine 26 (2008) 6529-6541
2. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 (2003) 218-226
3. Gerend M.A., and Magloire Z.F. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 42 (2008) 237-242
4. Boehner C.W., Howe S.R., Bernstein D.I., and Rosenthal S.L. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 30 (2003) 774-778
5. Jones M., and Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 57 (2008) 23-32
6. Ascherio A., Zhang S.M., Hernàn M.A., Olek M.J., Coplan P.M., Brodovicz K., et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344 (2001) 327-332
7. Confavreux C., Suissa S., Saddier P., Bourdès V., Vukusic S., and Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 344 (2001) 319-326
8. European Cervical Cancer Association (ECCA). HPV vaccination across Europe (http://www.ecca.info).
9. Kim J.J., and Goldie S.J. Health and economic implications of HPV vaccination in the United States. N Engl J Med 359 (2008) 821-832
10. Winer R.L., Feng Q., Hughes J.P., O'Reilly S., Kiviat N.B., and Koutsky L.A. Risk of female human papillomavirus acquisition associated with first male sexpartner. J Infect Dis 197 (2008) 279-282
11. Dempsey A.F. Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated. Rev Obstet Gynecol 1 (2008) 122-128
12. Ault K.A. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol Suppl. (2006) 40470